Global Clinical Biomarker Testing Market Analysis, 2020

By Type (Cancer,Metabolism, Infectious Disease, Cardiology, Neurology, Immunological Disease), By Application (Drug discovery, Nutrigenomics, Toxicology Testing, Personalized medicine, Functional Geno... ... ine, Functional Genomics), By End-User (Pharma and Biotech Companies, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Research Institutes), By Country (US, Canada, Mexico, Brazil, Argentina, UK, Germany, Italy, Spain, China, India, Japan, South Korea, Australia, UAE, Saudi Arabia), By Company Read more

  • Healthcare
  • Jul 2020
  • 178
  • PDF, Excel, PPT

Global Clinical Biomarker Testing Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Clinical Biomarker Testing market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The growing aging population coupled with rising rates of obesity are the major factors for the growth of biomarker testing. Other factors include emerging number of cancer therapies, advancement of bioinformatics. These reasons are expected to further drive the growth of clinical biomarker testing growth during 2020-25. According to MarkNtel Advisors’ research report titled “Global Clinical Biomarker Testing Market Analysis, 2020”, the Global Clinical Biomarker Testing market is anticipated to grow at a substantial CAGR during 2020-25. However, the high cost of cancer biomarker testing is currently restraining the market growth. 

Cancer Immunotherapy Segment Acquired a Prominent Market Share
The cancer immunotherapy segment growth is constantly escalating owing to the rising prevalence of pancreas cancer, stomach cancer, breast cancer, collateral cancer, and prostate cancer. Advancement of diagnosing techniques such as transcriptomic, genomics, proteomics and metabolomics is expected to propel the growth of biomarker testing market during 2020-25. Rising awareness in healthcare professionals for an early diagnosing procedure and a rise in government funding for treatment of different diseases are expected to bolster the demand for clinical biomarker testing during the forecast period as stated in the MarkNtel Advisors’ research report “Global Clinical Biomarker Testing Market Analysis, 2020”.  

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Expert Verbatim- Interview Excerpts of 10 industry experts
  4. Global Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
        1. Cancer
        2. Metabolism
        3. Infectious Disease
        4. Cardiology
        5. Neurology
        6. Immunological Disease
      2.  By Application
        1. Drug discovery
        2. Nutrigenomics
        3. Toxicology Testing
        4. Personalized medicine
        5. Functional Genomics
      3.  By End-User
        1. Pharma and Biotech Companies
        2. Diagnostic Tool Companies
        3. Healthcare IT/Big Data Companies
        4. Clinical Laboratories
        5. Research Institutes
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      5. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  5. North America Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. US
        2. Canada
        3. Mexico
    3. US Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Canada Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. Mexico Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  6. South America Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Argentina Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  7. Europe Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Germany Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. France Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    6. Italy Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    7. Spain Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  8. Asia-Pacific Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. South Korea
        6. Others
    3. China Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. India Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    5. Japan Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    6. Australia Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    7. South Korea Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  9. Middle East and Africa Clinical Biomarker Testing Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Type
      2. By Application
      3. By End-User
      4. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
    3. UAE Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
    4. Saudi Arabia Clinical Biomarker Testing Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
  10. Global Clinical Biomarker Testing Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  11. Global Clinical Biomarker Testing Regulations, Product Standards
  12. Global Clinical Biomarker Testing Value Chain Analysis
  13. Global Clinical Biomarker Testing Intellectual Property Rights Analysis
  14. Global Clinical Biomarker Testing Hotspots & Opportunities
  15. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
    2. Company Profiles
      1. Abbott Laboratories
      2. Adaptive Biotechnologies
      3. Becton Dickinson
      4. Bio-Rad Laboratories
      5. Agilent Technologies
      6. Hologic
      7. Merck and Co.
      8. Thermofisher Scientiifc
      9. Danaher Corporation
      10. AbbVie Inc.
  16.  Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message: